Home/Immix Biopharma/Ilya Rachman
IR

Ilya Rachman

Chief Executive Officer

Immix Biopharma

Therapeutic Areas

Immix Biopharma Pipeline

DrugIndicationPhase
NXC-201Relapsed/Refractory AL AmyloidosisPhase 1b/2a